Douglas Peters, PhD
About Douglas Peters, PhD
Douglas Peters, PhD, is the Senior Manager of Digital Pathology at Inotiv, where he has worked since 2023. He has over a decade of experience in fluorescence microscopy and has developed image analysis tools to study viral replication mechanisms during his doctoral research.
Current Role at Inotiv
Douglas Peters, PhD, serves as the Senior Manager of Digital Pathology at Inotiv, a position he has held since 2023. In this role, he oversees digital pathology initiatives, focusing on integrating advanced imaging techniques with pathology workflows. His work is based in Boulder, Colorado, where he applies his extensive background in fluorescence microscopy and image analysis to enhance diagnostic processes.
Previous Experience at Inotiv
Prior to his current role, Douglas Peters worked at Inotiv in various capacities. He was an Imaging Scientist from 2021 to 2022, where he contributed to imaging projects. He then advanced to the position of Manager of Fluorescent Digital Services from 2022 to 2023, leading efforts in fluorescence imaging. His tenure at Inotiv spanned a total of 18 months.
Academic Background
Douglas Peters earned his Doctor of Philosophy (PhD) in Cellular and Molecular Biology from the University of Colorado Boulder, where he studied from 2013 to 2020. He also holds a Bachelor of Arts (BA) in Neuroscience and Biology from Augustana College, completed from 2009 to 2013. His academic training laid the foundation for his research in molecular biology and imaging techniques.
Research and Development Experience
During his doctoral research, Douglas Peters developed bespoke image analysis tools to study mechanisms of viral replication. He conducted research that paired fluorescence microscopy with these tools, contributing to a deeper understanding of viral biology. His experience includes over 10 years of utilizing fluorescence microscopy for biological research, showcasing his expertise in this area.
Passion for Molecular Biology
Douglas Peters possesses a strong passion for leveraging molecular biology research to enhance quality of life. This commitment drives his work in digital pathology and his ongoing contributions to the field of biological research. His focus on improving diagnostic methods reflects his dedication to applying scientific knowledge for practical benefits.